Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications - PubMed
- ️Wed Jan 01 2020
Review
Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications
Krishna G Aragam et al. Circ Res. 2020.
Abstract
An individual's susceptibility to atherosclerotic cardiovascular disease is influenced by numerous clinical and lifestyle factors, motivating the multifaceted approaches currently endorsed for primary and secondary cardiovascular disease prevention. With growing knowledge of the genetic basis of atherosclerotic cardiovascular disease-in particular, coronary artery disease-and its contribution to disease pathogenesis, there is increased interest in understanding the potential clinical utility of a genetic predictor that might further refine the assessment and management of atherosclerotic cardiovascular disease risk. Rapid scientific and technological advances have enabled widespread genotyping efforts and dynamic research in the field of coronary artery disease genetic risk prediction. In this review, we describe how genomic analyses of coronary artery disease have been leveraged to create polygenic risk scores. We then discuss evaluations of the clinical utility of these scores, pertinent mechanistic insights gleaned, and practical considerations relevant to the implementation of polygenic risk scores in the health care setting.
Keywords: atherosclerosis; cardiovascular disease; coronary artery disease; genome-wide association study; genotype.
Figures

Genome-wide association studies have identified 164 genetic risk loci associated with coronary artery disease, with many classified into distinct mechanistic pathways. From Erdmann et al. Cardiovascular Research 2018.

Development of polygenic risk scores. Modified from Choi et al. bioRxiv 2018.

Genome-wide polygenic risk scores: (A) identify a marked, inherited predisposition to CAD; (B) provide lifetime estimates of risk; and (C) add to the discriminative ability of clinical risk factors. Panel (A) from Khera et al. Nature Genetics 2018. Panels (B) and (C) from Inouye et al. JACC 2018.

Polygenic risk score as the “first risk factor” for coronary artery disease.
Similar articles
-
Clinical utility of polygenic risk scores for coronary artery disease.
Klarin D, Natarajan P. Klarin D, et al. Nat Rev Cardiol. 2022 May;19(5):291-301. doi: 10.1038/s41569-021-00638-w. Epub 2021 Nov 22. Nat Rev Cardiol. 2022. PMID: 34811547 Free PMC article. Review.
-
Liou L, Kaptoge S, Dennis J, Shah M, Tyrer J, Inouye M, Easton DF, Pharoah PDP. Liou L, et al. Breast Cancer Res. 2021 Sep 30;23(1):94. doi: 10.1186/s13058-021-01465-0. Breast Cancer Res. 2021. PMID: 34593009 Free PMC article.
-
Elliott J, Bodinier B, Bond TA, Chadeau-Hyam M, Evangelou E, Moons KGM, Dehghan A, Muller DC, Elliott P, Tzoulaki I. Elliott J, et al. JAMA. 2020 Feb 18;323(7):636-645. doi: 10.1001/jama.2019.22241. JAMA. 2020. PMID: 32068818 Free PMC article.
-
Hindy G, Aragam KG, Ng K, Chaffin M, Lotta LA, Baras A; Regeneron Genetics Center; Drake I, Orho-Melander M, Melander O, Kathiresan S, Khera AV. Hindy G, et al. Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2738-2746. doi: 10.1161/ATVBAHA.120.314856. Epub 2020 Sep 22. Arterioscler Thromb Vasc Biol. 2020. PMID: 32957805 Free PMC article.
-
Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype?
German CA, Shapiro MD. German CA, et al. Curr Atheroscler Rep. 2021 Jun 28;23(9):47. doi: 10.1007/s11883-021-00950-3. Curr Atheroscler Rep. 2021. PMID: 34181090 Review.
Cited by
-
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations.
Dikilitas O, Schaid DJ, Tcheandjieu C, Clarke SL, Assimes TL, Kullo IJ. Dikilitas O, et al. Curr Cardiol Rep. 2022 Sep;24(9):1169-1177. doi: 10.1007/s11886-022-01734-0. Epub 2022 Jul 7. Curr Cardiol Rep. 2022. PMID: 35796859 Free PMC article. Review.
-
Genetics-based risk scores for prediction of premature coronary artery disease.
Gupta R. Gupta R. Indian Heart J. 2023 Sep-Oct;75(5):327-334. doi: 10.1016/j.ihj.2023.08.003. Epub 2023 Aug 25. Indian Heart J. 2023. PMID: 37633460 Free PMC article. Review.
-
Analysing electrocardiographic traits and predicting cardiac risk in UK biobank.
Ramírez J, van Duijvenboden S, Young WJ, Orini M, Jones AR, Lambiase PD, Munroe PB, Tinker A. Ramírez J, et al. JRSM Cardiovasc Dis. 2021 Jun 12;10:20480040211023664. doi: 10.1177/20480040211023664. eCollection 2021 Jan-Dec. JRSM Cardiovasc Dis. 2021. PMID: 34211707 Free PMC article. Review.
-
Zhang Y, Karakikes I. Zhang Y, et al. Trends Cardiovasc Med. 2021 Aug;31(6):341-348. doi: 10.1016/j.tcm.2020.06.008. Epub 2020 Jun 27. Trends Cardiovasc Med. 2021. PMID: 32603681 Free PMC article. Review.
-
The Questions on Everyone's Mind: What is and Why Do We Need Preventive Cardiology?
Mahmood T, Shapiro MD. Mahmood T, et al. Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):8-14. doi: 10.14797/mdcvj.698. eCollection 2021. Methodist Debakey Cardiovasc J. 2021. PMID: 34824677 Free PMC article. Review.
References
-
- Gertler MM, Garn SM and White PD. Young candidates for coronary heart disease. J Am Med Assoc. 1951;147:621–5. - PubMed
-
- Thomas CB and Cohen BH. The familial occurrence of hypertension and coronary artery disease, with observations concerning obesity and diabetes. Ann Intern Med. 1955;42:90–127. - PubMed
-
- White PD. Genes, the heart and destiny. N Engl J Med. 1957;256:965–9. - PubMed
-
- Lloyd-Jones DM, Nam BH, D’Agostino RB, Sr., Levy D, Murabito JM, Wang TJ, Wilson PW and O’Donnell CJ. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291:2204–11. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical